• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device immunoassay for detection of amniotic fluid protein(s).
Definition The test is for use by health care professionals to aid in the detection of fetal membrane rupture in pregnant women, when they report signs, symptoms or complaints suggestive of such rupture.
Product CodeNQM
Regulation Number 862.1550
Device Class 1

MDR Year MDR Reports MDR Events
2017 3 3
2018 7 7
2019 5 5
2020 5 5
2022 1 1

Device Problems MDRs with this Device Problem Events in those MDRs
False Negative Result 7 7
Incorrect, Inadequate or Imprecise Result or Readings 4 4
Component Missing 2 2
Adverse Event Without Identified Device or Use Problem 2 2
Difficult to Remove 2 2
False Positive Result 1 1
Failure of Device to Self-Test 1 1
Device Damaged Prior to Use 1 1
Fluid/Blood Leak 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Known Impact Or Consequence To Patient 9 9
Death, Intrauterine Fetal 3 3
No Information 2 2
No Code Available 1 1
Hemorrhage/Bleeding 1 1
Foreign Body In Patient 1 1
Fluid Discharge 1 1
Abscess 1 1
No Consequences Or Impact To Patient 1 1
Chorioamnionitis 1 1
Device Embedded In Tissue or Plaque 1 1

Recalls
Manufacturer Recall Class Date Posted
1 Clinical Innovations, LLC II Dec-07-2020
2 Qiagen Sciences LLC II Apr-01-2020
3 Qiagen Sciences, Inc. I Jul-13-2018
-
-